![]() |
sponsored links |
|
|
sponsored links
|
|
|
3
11th July 21:08
External User
Posts: 1
|
Don't listen to this guy. He has his soapbox and he keeps repeating the
same arguments. He actually know very little about prostate cancer. There is a germ of truth in what he says. There have been a variety of studies trying to determine how effective various forms of treatment for prostate cancer may be. Right now the evidence is somewhat ambiguous. The most important thing to keep in mind is that such studies may be of limited value for helping any given man decide what to do. Prostate cancer is a complex disease, and a lot depends on the details of the individual case. For example, it is possible that in the fullness of time, it will be shown that many of the men who currently are treated for early prostate cancer aggressively need not have been treated and would never have had a problem with the disease. For example, one study based on Medicare data, showed that 15 percent of men of European descent and 35 percent of African American men might be in that category. (That is only one study, and I wouldn't take those figures too seriously.) Unfortunately, no one knows a way easily to distinguish those cases needing treatment from those that don't. If you have been diagnosed with early prostate cancer, and you would normally have a life expectancy of at least 10 years, then it is reasonable to consider aggressive treatment. The younger you are the more that is the case. On the other hand if you are over 80, it is not even clear you should be tested to see if you have prostate cancer, and aggressive treatment would only be called for in exceptional cases. Men in the middle range have to consider all the available information in making a decision. In any case, when all is said on done, you have to rely on physicians you trust, not on people with soapboxes, including me, whom you meet through the internet. Harvard, by the way, to the best of my knowledge, is not a major center for brachytherapy. -- Leonard Evens len@math.northwestern.edu 847-491-5537 Dept. of Mathematics, Northwestern Univ., Evanston, IL 60208 |
|
|
7
5th August 12:41
External User
Posts: 1
|
What kind of response do you want? If I remember correctly, you asked
how proton beam therapy differed from conventional radiation therapy, and you got at least a couple of responses explaining the differences, one from me. You might try alt.support.cancer.prostate. One of the men who participates there has had proton beam therapy and he is very happy with the results. -- Leonard Evens len@math.northwestern.edu 847-491-5537 Dept. of Mathematics, Northwestern Univ., Evanston, IL 60208 |
|
|
8
5th August 12:41
External User
Posts: 1
|
NEW ANTICANCER REMEDY This anticancer drug is developed in Latvia from
Stinkhorn mushroom (Phallus Impudicus). It is an edible mushroom, which was used in folk-medicine for centuries The remedy is a lotion for external use. The lotion is made on a basis of triethanolamin and stearic acid - the most common basis for cosmetics. Such basis penetrates the skin and tissues. Stinkhorn is an edible mushroom. Harmlessness of the lotion is guaranteed, It gives no unwanted side-effects. It can be used as the only treatment or together with any other treatment. This lotion can be used also to dissolve benign tumors, like ovarian cysts. See internet ;http://www.Ralphmoss.com/stink.html For more information contact: Iosef Gurvich, P.O.Box 4059, Jersey City, NJ 07304, USA Tel"(201)418-8827 , e-mail: Sebezh70@aol.com |
|